deCODE Announces Appointment of Dr. Linda Buck to Board of Directors
Complete the form below to unlock access to ALL audio articles.
deCODE genetics has announced that it has named Dr. Linda Buck to join its Board of Directors, effective immediately.
Dr. Buck, who received a Nobel Prize in physiology or medicine in 2004 for her discoveries on the workings of the olfactory system, is Associate Director of the Basic Sciences Division at Fred Hutchinson Cancer Research Center in Seattle and is a Howard Hughes Medical Institute investigator.
She also is an affiliate professor of physiology and biophysics at the University of Washington.
"It is a great pleasure to welcome Linda to our board," said Kari Stefansson, CEO of deCODE.
"Linda is recognized around the world as a pioneer in utilizing molecular biology for discovering a new understanding of complex biological systems, expertise that I believe will enable her to make a valuable contribution to our efforts to apply human genetics to make better medicine."
"As a former colleague I know how fortunate we are to have a scientist and person of Linda's distinction join our board, and we look forward to working with her," Stefansson said.
Dr. Buck is the author of numerous scientific publications and the recipient of many honors and awards for her research.
Prior to her current positions, Dr. Buck was a professor of neurobiology at Harvard Medical School.
Dr. Buck holds BS degrees in psychology and microbiology from the University of Washington, and she received her PhD in immunology from the University of Texas Southwestern Medical Center at Dallas.
